|
Total
|
10325
|
70.9
|
4829 (46.8)
|
3183 (65.9)
|
753 (15.6)
|
532 (11.0)
|
361 (7.5)
|
|
Myeloma
|
1399
|
73.0
|
887 (63.4)
|
572 (64.5)
|
139 (15.7)
|
107 (12.0)
|
69 (7.8)
|
|
Diffuse large B-cell lymphoma
|
1604
|
70.4
|
831 (51.8)
|
535 (64.5)
|
122 (14.7)
|
94 (11.3)
|
80 (9.6)
|
|
Myelodysplastic syndromes
|
794
|
76.0
|
595 (74.9)
|
422 (70.9)
|
94 (15.8)
|
44 (7.4)
|
35 (5.9)
|
|
Acute myeloid leukaemia
|
722
|
71.1
|
573 (79.4)
|
413 (72.1)
|
81 (14.1)
|
41 (7.2)
|
38 (6.6)
|
|
Chronic lymphocytic leukaemia
|
1279
|
71.6
|
424 (33.2)
|
276 (65.1)
|
74 (17.5)
|
50 (11.8)
|
24 (5.6)
|
|
Myeloproliferative neoplasms
|
1187
|
71.2
|
283 (23.8)
|
161 (56.9)
|
50 (17.7)
|
53 (18.7)
|
19 (6.7)
|
|
Marginal zone lymphoma
|
625
|
72.2
|
229 (36.6)
|
141 (61.6)
|
28 (12.2)
|
42 (18.3)
|
18 (7.9)
|
|
Lymphoproliferative disorder NOS2
|
378
|
77.0
|
165 (43.7)
|
101 (61.2)
|
26 (15.8)
|
30 (18.2)
|
8 (4.8)
|
|
Follicular lymphoma
|
656
|
64.5
|
148 (22.6)
|
91 (61.5)
|
29 (19.6)
|
16 (10.8)
|
12 (8.1)
|
|
Hodgkin lymphoma
|
576
|
44.4
|
126 (21.9)
|
94 (74.6)
|
17 (13.5)
|
10 (7.9)
|
5 (4.0)
|
|
Mantle cell lymphoma
|
173
|
74.0
|
123 (71.1)
|
66 (53.7)
|
24 (19.5)
|
13 (10.6)
|
20 (16.2)
|
|
T-cell lymphoma
|
206
|
64.9
|
117 (56.8)
|
83 (70.9)
|
20 (17.1)
|
5 (4.3)
|
9 (7.7)
|
|
Chronic myelomonocytic leukaemia
|
127
|
77.4
|
89 (70.1)
|
64 (71.9)
|
16 (18.0)
|
7 (7.9)
|
2 (2.2)
|
|
Acute lymphoblastic leukaemia
|
112
|
47.5
|
77 (68.8)
|
53 (68.8)
|
10 (13.0)
|
4 (5.2)
|
10 (13.0)
|
|
Primary myelofibrosis
|
88
|
74.1
|
49 (55.7)
|
34 (69.4)
|
8 (16.3)
|
3 (6.1)
|
4 (8.2)
|
|
Chronic myeloid leukaemia
|
203
|
59.2
|
44 (21.7)
|
32 (72.7)
|
4 (9.1)
|
5 (11.4)
|
3 (6.8)
|
|
Burkitt lymphoma
|
53
|
57.6
|
30 (56.6)
|
21 (70.0)
|
5 (16.6)
|
2 (6.7)
|
2 (6.7)
|
|
T-cell leukaemia
|
80
|
74.7
|
30 (37.5)
|
19 (63.3)
|
4 (13.3)
|
5 (16.7)
|
2 (6.7)
|
|
Hairy cell leukaemia
|
63
|
65.5
|
9 (14.3)
|
5 (55.6)
|
2 (22.2)
|
1 (11.1)
|
1 (11.1)
|
